Wnt-3a utilizes a novel low dose and rapid pathway that does not require casein kinase 1-mediated phosphorylation of Dvl to activate beta-catenin.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples